T. Kawasaki, Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerug? Allergy, pp.178-222, 1967.

T. Kawasaki and S. Naoe, History of Kawasaki disease, Clinical and Experimental Nephrology, vol.22, issue.2, pp.301-305
DOI : 10.1007/s10157-013-0877-6

Y. Nakamura, M. Yashiro, R. Uehara, A. Sadakane, I. Chihara et al., Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2007???2008 Nationwide Survey, Journal of Epidemiology, vol.20, issue.4, pp.302-309, 2010.
DOI : 10.2188/jea.JE20090180

R. Uehara and E. Belay, Epidemiology of Kawasaki Disease in Asia, Europe, and the United States, Journal of Epidemiology, vol.22, issue.2, pp.79-85, 2012.
DOI : 10.2188/jea.JE20110131

D. Burgner and A. Harnden, Kawasaki disease: What is the epidemiology telling us about the etiology?, International Journal of Infectious Diseases, vol.9, issue.4, pp.185-94, 2005.
DOI : 10.1016/j.ijid.2005.03.002

X. Rodó, J. Ballester, D. Cayan, M. Melish, Y. Nakamura et al., Association of Kawasaki disease with tropospheric wind patterns, Scientific Reports, vol.29, issue.1, p.152, 2011.
DOI : 10.1007/s00382-007-0251-z

X. Rodó, R. Curcoll, M. Robinson, J. Ballester, J. Burns et al., Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan, Proceedings of the National Academy of Sciences, vol.111, issue.22, pp.7952-7959, 2014.
DOI : 10.1073/pnas.1400380111

H. Jorquera, A. Borzutzky, R. Hoyos-bachiloglu, and A. García, Association of Kawasaki disease with tropospheric winds in Central Chile: Is wind-borne desert dust a risk factor?, Environment International, vol.78, pp.32-40, 2015.
DOI : 10.1016/j.envint.2015.02.007

I. Koné-paut, M. Darce-bello, A. Arnoux, and M. Piram, Donn??es ??pid??miologiques de la maladie de Kawasaki en France : le registre KAWANET, Archives de P??diatrie, vol.20, issue.5, pp.67-69, 2013.
DOI : 10.1016/S0929-693X(13)71325-3

Y. Nakamura, M. Yashiro, R. Uehara, A. Sadakane, S. Tsuboi et al., Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey, Journal of Epidemiology, vol.22, issue.3, pp.216-237, 2012.
DOI : 10.2188/jea.JE20110126

J. Burns, Finding Kawasaki disease, Ann Pediatr Cardiol. 2012, vol.5, issue.2, pp.133-137

K. Ha, G. Jang, J. Lee, K. Lee, Y. Hong et al., Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis, European Journal of Pediatrics, vol.44, issue.5, 2013.
DOI : 10.1007/s00431-012-1891-5

M. Piram and I. Koné-paut, Kawasaki disease: what's new in 2012?]. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie, pp.1012-1016, 2012.

J. Joint and W. Group, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease Digest version, Circ J Off J Jpn Circ Soc, vol.78, issue.10, pp.2521-62, 2013.

E. Salo, E. Griffiths, T. Farstad, B. Schiller, Y. Nakamura et al., Incidence of Kawasaki disease in northern European countries, Pediatrics International, vol.192, issue.7351, pp.770-772, 2012.
DOI : 10.1111/j.1442-200X.2012.03692.x

J. Burns, D. Cayan, G. Tong, E. Bainto, C. Turner et al., Seasonality and Temporal Clustering of Kawasaki Syndrome, Epidemiology, vol.16, issue.2, pp.220-225, 2005.
DOI : 10.1097/01.ede.0000152901.06689.d4

J. Hui-yuen, T. Duong, and R. Yeung, TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease, J Immunol Baltim Md, vol.176, issue.10, pp.6294-301, 1950.

J. Burns and M. Glodé, Kawasaki syndrome. Lancet, Aug, vol.7364, issue.9433, pp.533-577, 2004.

C. Shimizu, T. Matsubara, Y. Onouchi, S. Jain, S. Sun et al., Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease, Journal of Human Genetics, vol.63, issue.12, pp.779-84, 2010.
DOI : 10.1038/jhg.2010.109

F. Bajolle and L. Maladie-de-kawasaki, du diagnostic a? la the?rapeutiquethe?rapeutique, Ho? pital Necker, consulteén avril 2014 sur : http://carpedem, 2012.

D. Leung, H. Meissner, D. Fulton, D. Murray, B. Kotzin et al., Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome, The Lancet, vol.342, issue.8884, pp.1385-1393, 1993.
DOI : 10.1016/0140-6736(93)92752-F

Y. Nomura, K. Masuda, M. Yoshinaga, S. Takei, and K. Miyata, Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age, The Pediatric Infectious Disease Journal, vol.22, issue.9, pp.794-802, 2003.
DOI : 10.1097/01.inf.0000083824.15218.de

D. Leung, H. Meissner, S. Shulman, W. Mason, M. Gerber et al., Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease, The Journal of Pediatrics, vol.140, issue.6, pp.742-748, 2002.
DOI : 10.1067/mpd.2002.123664

A. Rowley and S. Shulman, New developments in the search for the etiologic agent of Kawasaki disease, Current Opinion in Pediatrics, vol.19, issue.1, pp.71-75, 2007.
DOI : 10.1097/MOP.0b013e328012720f

H. Yanagawa, M. Yashiro, Y. Nakamura, T. Kawasaki, and H. Kato, Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in, Pediatrics, 1991.

J. Lou, S. Xu, L. Zou, R. Zhong, T. Zhang et al., A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis, Molecular Biology Reports, vol.361, issue.12, 2012.
DOI : 10.1007/s11033-012-2022-0

Y. Onouchi, T. Gunji, J. Burns, C. Shimizu, J. Newburger et al., ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms, Nature Genetics, vol.25, issue.1, pp.35-42, 2008.
DOI : 10.1038/ng.2007.59

Y. Onouchi, Genetics of Kawasaki Disease, Circulation Journal, vol.76, issue.7, pp.1581-1587, 2012.
DOI : 10.1253/circj.CJ-12-0568

Y. Onouchi, Susceptibility genes for Kawasaki disease], Nihon Rinsho Jpn J Clin Med, 2014.

M. Ayusawa, T. Sonobe, S. Uemura, S. Ogawa, Y. Nakamura et al., Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition), Pediatrics International, vol.53, issue.2, 2005.
DOI : 10.1111/j.1442-200x.2005.02033.x

J. Newburger, M. Takahashi, M. Gerber, M. Gewitz, L. Tani et al., Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, PEDIATRICS, vol.114, issue.6, pp.2747-71, 2004.
DOI : 10.1542/peds.2004-2182

F. Bajolle and D. Laux, Kawasaki disease: what you need to know. Arch Pédiatrie Organe Off Sociéte Fr Pédiatrie, pp.1264-1272, 2012.

A. Baker, M. Lu, L. Minich, A. Atz, G. Klein et al., Associated Symptoms in the Ten Days Before Diagnosis of Kawasaki Disease, The Journal of Pediatrics, vol.154, issue.4, pp.592-595, 2009.
DOI : 10.1016/j.jpeds.2008.10.006

F. Chang, B. Hwang, S. Chen, P. Lee, C. Meng et al., Characteristics of Kawasaki Disease in Infants Younger than Six Months of Age, The Pediatric Infectious Disease Journal, vol.25, issue.3, pp.241-245, 2006.
DOI : 10.1097/01.inf.0000202067.50975.90

A. Kentsis, A. Shulman, S. Ahmed, E. Brennan, M. Monuteaux et al., Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease, EMBO Molecular Medicine, vol.7, issue.2, pp.210-230, 2013.
DOI : 10.1002/emmm.201201494

A. Tremoulet, J. Dutkowski, Y. Sato, J. Kanegaye, X. Ling et al., Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease. Pediatr Res, 2015.

P. Parthasarathy, A. Agarwal, K. Chawla, T. Tofighi, and T. Mondal, Upcoming biomarkers for the diagnosis of Kawasaki disease: A review, Clinical Biochemistry, vol.48, issue.16-17, 2015.
DOI : 10.1016/j.clinbiochem.2015.02.013

K. Durongpisitkul, V. Gururaj, J. Park, and C. Martin, The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment, Pediatrics, vol.96, issue.6, pp.1057-61, 1995.

J. Joint and W. Group, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version, Circ J Off J Jpn Circ Soc, vol.74, issue.9, pp.1989-2020, 2010.

L. Zhao, Y. Wang, and L. Suo, Meta-analysis of the risk factors for coronary artery lesion secondary to Kawasaki disease in Chinese children], Zhonghua Er Ke Za Zhi Chin J Pediatr, vol.49, issue.6, pp.459-67, 2011.

J. Gordon, A. Kahn, and J. Burns, When Children With Kawasaki Disease Grow Up, Journal of the American College of Cardiology, vol.54, issue.21, pp.1911-1931, 2009.
DOI : 10.1016/j.jacc.2009.04.102

F. Bajolle, D. Bonnet, and . La-maladie-de-kawasaki-en-quatre-tableaux, Available from: http://www.realites-cardiologiques, 2011.

N. Alves, M. Magalhães, C. De, R. Almeida, F. De et al., Prospective study of Kawasaki disease complications: review of 115 cases. Rev Assoc Médica Bras, pp.295-300, 1992.

C. Magalhães, M. Alves, N. Oliveira, K. Silva, I. Gandolfi et al., Sensorineural Hearing Loss, JCR: Journal of Clinical Rheumatology, vol.16, issue.7, pp.322-327, 2010.
DOI : 10.1097/RHU.0b013e3181f603bc

S. Dominguez, M. Anderson, M. El-adawy, and M. Glodé, Preventing Coronary Artery Abnormalities, The Pediatric Infectious Disease Journal, vol.31, issue.12, p.2012
DOI : 10.1097/INF.0b013e318266bcf9

J. Newburger, M. Takahashi, A. Beiser, J. Burns, J. Bastian et al., A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome, New England Journal of Medicine, vol.324, issue.23, pp.1633-1642, 1991.
DOI : 10.1056/NEJM199106063242305

T. Kobayashi, Y. Inoue, K. Takeuchi, Y. Okada, K. Tamura et al., Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease, Circulation, vol.113, issue.22, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.592865

T. Sano, S. Kurotobi, K. Matsuzaki, T. Yamamoto, I. Maki et al., Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment, European Journal of Pediatrics, vol.55, issue.4, pp.131-138, 2007.
DOI : 10.1007/s00431-006-0223-z

K. Egami, H. Muta, M. Ishii, K. Suda, Y. Sugahara et al., Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease, The Journal of Pediatrics, vol.149, issue.2, 2006.
DOI : 10.1016/j.jpeds.2006.03.050

L. Sleeper, L. Minich, B. Mccrindle, J. Li, W. Mason et al., Evaluation of Kawasaki Disease Risk-Scoring Systems for Intravenous Immunoglobulin Resistance, The Journal of Pediatrics, vol.158, issue.5, 2011.
DOI : 10.1016/j.jpeds.2010.10.031

D. Eleftheriou, M. Levin, D. Shingadia, R. Tulloh, N. Klein et al., Management of Kawasaki disease, Archives of Disease in Childhood, vol.5, issue.1, pp.74-83, 2014.
DOI : 10.1136/archdischild-2012-302841

H. Kato, S. Koike, and T. Yokoyama, Kawasaki disease: effect of treatment on coronary artery involvement, Pediatrics. Feb, vol.63, issue.2, pp.175-184, 1979.

T. Kobayashi, T. Saji, T. Otani, K. Takeuchi, T. Nakamura et al., Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial, The Lancet, vol.379, issue.9826, pp.1613-1633, 2012.
DOI : 10.1016/S0140-6736(11)61930-2

J. Newburger, Adding prednisolone to standard immunoglobulin therapy is beneficial for patients with severe Kawasaki disease, The Journal of Pediatrics, vol.161, issue.5, p.967, 2012.
DOI : 10.1016/j.jpeds.2012.08.049

S. Chen, Y. Dong, Y. Yin, and M. Krucoff, Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis, Heart, vol.99, issue.2, 2013.
DOI : 10.1136/heartjnl-2012-302126

K. Okada, J. Hara, I. Maki, K. Miki, K. Matsuzaki et al., Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease, European Journal of Pediatrics, vol.128, issue.2, pp.181-186, 2009.
DOI : 10.1007/s00431-008-0727-9

C. Tacke, D. Burgner, I. Kuipers, and T. Kuijpers, Management of acute and refractory Kawasaki disease, Expert Review of Anti-infective Therapy, vol.10, issue.10, pp.1203-1218, 2012.
DOI : 10.1586/eri.12.101

A. Tremoulet, S. Jain, P. Jaggi, S. Jimenez-fernandez, J. Pancheri et al., Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial, The Lancet, vol.383, issue.9930, pp.1731-1739, 2014.
DOI : 10.1016/S0140-6736(13)62298-9

T. Heuclin, F. Dubos, V. Hue, F. Godart, C. Francart et al., Increased Detection Rate of Kawasaki Disease Using New Diagnostic Algorithm, Including Early Use of Echocardiography, The Journal of Pediatrics, vol.155, issue.5, pp.695-699, 2009.
DOI : 10.1016/j.jpeds.2009.04.058

P. Jaggi, A. Kajon, A. Mejias, O. Ramilo, and A. Leber, Human Adenovirus Infection in Kawasaki Disease: A Confounding Bystander? Clin Infect Dis, pp.58-64, 2013.

Y. Nakamura, Epidemiology of Kawasaki disease], Nihon Rinsho Jpn J Clin Med, 2014.

J. Saundankar, D. Yim, B. Itotoh, R. Payne, K. Maslin et al., The Epidemiology and Clinical Features of Kawasaki Disease in Australia, PEDIATRICS, vol.133, issue.4, pp.1009-1014
DOI : 10.1542/peds.2013-2936

Y. Nakamura, Epidemiologic features of Kawasaki disease], Nihon Rinsho Jpn J Clin Med. Feb, vol.66, issue.2, pp.229-263, 2008.

C. Catalano-pons, C. Giraud, F. Rozenberg, J. Meritet, P. Lebon et al., Detection of human bocavirus in children with Kawasaki disease, Clinical Microbiology and Infection, vol.13, issue.12, pp.1220-1222, 2007.
DOI : 10.1111/j.1469-0691.2007.01827.x

J. Burns, L. Herzog, O. Fabri, A. Tremoulet, X. Rodo et al., Seasonality of Kawasaki Disease: A Global Perspective, PLoS ONE, vol.1, issue.9, 2013.
DOI : 10.1371/journal.pone.0074529.s001

R. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2015.

T. J. Aragon and . Developer, epitools: Epidemiology Tools. R package version 0, pp.5-7, 2012.